First-line zongertinib in patients with advanced HER2-mutant NSCLC: updated results from Beamion LUNG-1 (ESMO Asia 2026) - Oct 1, 2026 - Abstract #949RO; Pres time: Dec 5, 2026; 09:46 AM - 09:51 AM; Location: Hall 406; No abstract available
Clinical • Metastases • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • HER-2
|